Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference38 articles.
1. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group;Grimm;BJU Int,2012
2. Brachytherapy: Where has it gone?;Petereit;J Clin Oncol,2015
3. What is value in health care?;Porter;N Engl J Med,2010
4. Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: A systematic review;Whiting;BJU Int,2016
5. Quality of life and satisfaction with outcome among prostate-cancer survivors;Sanda;N Engl J Med,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study;Radiotherapy and Oncology;2023-06
2. Brachytherapie;Springer Reference Medizin;2022-11-15
3. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer;American Journal of Clinical Oncology;2022-05-06
4. American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy;Brachytherapy;2022-01
5. Monte Carlo simulation in medical physics;Nuclear Engineering Mathematical Modeling and Simulation;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3